🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jodie P. Goodridge

Fate Therapeutics (United States)

ORCID: 0000-0001-7531-6032

Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia”.

Dual antigen–targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia

Blood(2022)10.1182/blood.2021015184

N/A

0.665DataRank · unranked

83 citations

Jodie P. Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary Davis, Svetlana Gaidarova +15 more

Allelic variation of KIR and HLA tunes the cytolytic payload and determines functional hierarchy of NK cell repertoires

Blood Advances(2023)10.1182/bloodadvances.2023009827

N/A

0.345DataRank · unranked

9 citations

Sudan Tao, Dennis Clement, Alvaro Haroun-Izquierdo, Katherine M. Kichula, Herman Netskar +16 more

Quadruple gene-engineered natural killer cells enable multi-antigen targeting for durable antitumor activity against multiple myeloma

Nature Communications(2022)10.1038/s41467-022-35127-2

N/A

0DataRank · unranked

76 citations

Ryan Bjordahl, Jodie P. Goodridge, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour +18 more